Evaluating commercial viability on a pilot scale can be challenging
Having a promising idea for an animal health product is just the starting point. But before you invest time and resources in bringing it to life, it’s essential to have a robust understanding of its potential. This calls for a well-executed pilot study.
However, executing pilot studies for animal health products…
Can leave knowledge gaps if improperly executed
The pilot study is a pivotal moment in your development programme. Without data generated from robust tests and models, incomplete, inconclusive, or unreliable findings can lead to poor decision-making and late-stage disappointment.
Requires in-depth animal healthcare sector know-how
Demonstrating proof of concept for animal health products is fundamentally different to that for human therapeutics. Accurately evaluating the viability of your active ingredient or formulation therefore requires deep animal health sector knowledge and experience.
Can be complicated and resource intensive
The proof of concept stage may test your idea on a small scale — but it’s still a highly complex undertaking. Without efficient scheduling, underpinned by decades of animal health product experience, unexpected issues can cause excessive delays and blown budgets.
